Caitong International Asset Management Co. Ltd Has $1.60 Million Position in Tempus AI, Inc. $TEM

Caitong International Asset Management Co. Ltd grew its position in Tempus AI, Inc. (NASDAQ:TEM) by 38,059.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,093 shares of the company’s stock after acquiring an additional 27,022 shares during the period. Caitong International Asset Management Co. Ltd’s holdings in Tempus AI were worth $1,600,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. JPL Wealth Management LLC acquired a new position in Tempus AI in the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $27,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Tempus AI in the 3rd quarter valued at $38,000. Lodestone Wealth Management LLC bought a new stake in Tempus AI in the fourth quarter worth approximately $42,000. Finally, CoreCap Advisors LLC grew its stake in shares of Tempus AI by 135.1% in the 4th quarter. CoreCap Advisors LLC now owns 743 shares of the company’s stock valued at $44,000 after buying an additional 427 shares during the period. Institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on TEM shares. BTIG Research restated a “buy” rating and set a $80.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Stifel Nicolaus set a $60.00 target price on shares of Tempus AI in a research report on Wednesday, February 25th. Weiss Ratings restated a “sell (e+)” rating on shares of Tempus AI in a research note on Wednesday. Wolfe Research started coverage on shares of Tempus AI in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Finally, Wall Street Zen raised shares of Tempus AI from a “sell” rating to a “hold” rating in a report on Saturday, June 6th. Nine analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $68.64.

Insider Buying and Selling

In other Tempus AI news, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total value of $7,763,875.00. Following the sale, the chief executive officer directly owned 8,808,533 shares of the company’s stock, valued at approximately $411,358,491.10. This trade represents a 1.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Ryan M. Bartolucci sold 4,116 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $181,392.12. Following the completion of the transaction, the chief accounting officer owned 74,041 shares in the company, valued at $3,262,986.87. The trade was a 5.27% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 558,557 shares of company stock valued at $26,611,939 in the last three months. 24.26% of the stock is currently owned by company insiders.

Tempus AI Price Performance

TEM opened at $50.84 on Friday. Tempus AI, Inc. has a 52 week low of $41.73 and a 52 week high of $104.32. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. The firm has a 50-day simple moving average of $49.66 and a two-hundred day simple moving average of $55.90. The company has a market capitalization of $9.13 billion, a PE ratio of -29.56 and a beta of 3.62.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The business had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. During the same period last year, the company posted ($0.24) earnings per share. The company’s quarterly revenue was up 36.1% compared to the same quarter last year. Analysts forecast that Tempus AI, Inc. will post -1.35 earnings per share for the current fiscal year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.